1
|
Hu C, Zang N, Tam YT, Dizon D, Lee K, Pang J, Torres E, Cui Y, Yen CW, Leung DH. A New Approach for Preparing Stable High-Concentration Peptide Nanoparticle Formulations. Pharmaceuticals (Basel) 2023; 17:15. [PMID: 38276000 PMCID: PMC10821397 DOI: 10.3390/ph17010015] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/09/2023] [Revised: 12/11/2023] [Accepted: 12/15/2023] [Indexed: 01/27/2024] Open
Abstract
The subcutaneous administration of therapeutic peptides would provide significant benefits to patients. However, subcutaneous injections are limited in dosing volume, potentially resulting in high peptide concentrations that can incur significant challenges with solubility limitations, high viscosity, and stability liabilities. Herein, we report on the discovery that low-shear resonant acoustic mixing can be used as a general method to prepare stable nanoparticles of a number of peptides of diverse molecular weights and structures in water without the need for extensive amounts of organic solvents or lipid excipients. This approach avoids the stability issues observed with typical high-shear, high-intensity milling methods. The resultant peptide nanosuspensions exhibit low viscosity even at high concentrations of >100 mg/mL while remaining chemically and physically stable. An example nanosuspension of cyclosporine nanoparticles was dosed in rats via a subcutaneous injection and exhibited sustained release behavior. This suggests that peptide nanosuspension formulations can be one approach to overcome the challenges with high-concentration peptide formulations.
Collapse
Affiliation(s)
- Chloe Hu
- Synthetic Molecule Pharmaceutical Sciences, Genentech, Inc., 1 DNA Way, South San Francisco, CA 94080, USA; (C.H.); (N.Z.); (C.-W.Y.)
| | - Nanzhi Zang
- Synthetic Molecule Pharmaceutical Sciences, Genentech, Inc., 1 DNA Way, South San Francisco, CA 94080, USA; (C.H.); (N.Z.); (C.-W.Y.)
| | - Yu Tong Tam
- Pharmaceutical Development, Genentech, Inc., 1 DNA Way, South San Francisco, CA 940802, USA;
| | - Desmond Dizon
- Device Development, Genentech, Inc., 1 DNA Way, South San Francisco, CA 94080, USA;
| | - Kaylee Lee
- Drug Metabolism and Pharmacokinetics, Genentech, Inc., 1 DNA Way, South San Francisco, CA 94080, USA; (K.L.); (J.P.); (Y.C.)
| | - Jodie Pang
- Drug Metabolism and Pharmacokinetics, Genentech, Inc., 1 DNA Way, South San Francisco, CA 94080, USA; (K.L.); (J.P.); (Y.C.)
| | - Elizabeth Torres
- Development Sciences, Genentech, Inc., 1 DNA Way, South San Francisco, CA 94080, USA;
| | - Yusi Cui
- Drug Metabolism and Pharmacokinetics, Genentech, Inc., 1 DNA Way, South San Francisco, CA 94080, USA; (K.L.); (J.P.); (Y.C.)
| | - Chun-Wan Yen
- Synthetic Molecule Pharmaceutical Sciences, Genentech, Inc., 1 DNA Way, South San Francisco, CA 94080, USA; (C.H.); (N.Z.); (C.-W.Y.)
| | - Dennis H. Leung
- Synthetic Molecule Pharmaceutical Sciences, Genentech, Inc., 1 DNA Way, South San Francisco, CA 94080, USA; (C.H.); (N.Z.); (C.-W.Y.)
| |
Collapse
|
2
|
Lecot N, Rodríguez G, Stancov V, Fernández M, González M, Glisoni RJ, Cabral P, Cerecetto H. Development of fluorescent- and radio-traceable T1307-polymeric micelles as biomedical agents for cancer diagnosis: biodistribution on 4T1 tumor-bearing mice. BRAZ J PHARM SCI 2022. [DOI: 10.1590/s2175-97902022e191055] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/21/2022] Open
Affiliation(s)
| | | | | | | | | | | | | | - Hugo Cerecetto
- Universidad de la República, Uruguay; Universidad de la República, Uruguay
| |
Collapse
|
3
|
Lecot N, Dávila B, Sánchez C, Fernández M, González M, Cabral P, Cerecetto H, Glisoni R. Development and Evaluation of 2-Amino-7-Fluorophenazine 5,10-Dioxide Polymeric Micelles as Antitumoral Agents for 4T1 Breast Cancer. Polymers (Basel) 2021; 14:71. [PMID: 35012094 PMCID: PMC8747360 DOI: 10.3390/polym14010071] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/08/2021] [Revised: 12/18/2021] [Accepted: 12/22/2021] [Indexed: 11/23/2022] Open
Abstract
2-Amino-7-fluorophenazine 5,10-dioxide (FNZ) is a bioreducible prodrug, poorly soluble in water, with potential anticancer activity on hypoxic-tumors. This poor solubility limits its potential applications in clinic. Amphiphilic pristine polymeric micelles (PMs) based on triblock copolymers Pluronic® and Tetronic®, glycosylated derivatives and their mixtures with preformed-liposomes (LPS), were analyzed as strategies to improve the bioavailability of FNZ. FNZ encapsulations were performed and the obtaining nanostructures were characterized using UV-visible spectroscopy (UV-VIS), Transmission Electron Microscopy (TEM) and Dynamic Light Scattering (DLS). The most promising nanoformulations were analyzed for their potential toxicity and pharmacologically, at 20 mg/kg FNZ-doses, in a stage-IV murine metastatic-breast tumor model. The results revealed that the solubility of the encapsulated-FNZ increased up to 14 times and the analysis (UV-VIS, DLS and TEM) confirmed the interaction between vehicles and FNZ. In all the cases appropriate encapsulation efficiencies (greater than 75%), monodisperse nanometric particle sizes (PDI = 0.180-0.335), adequate Z-potentials (-1.59 to -26.4 mV), stabilities and spherical morphologies were obtained. The in vitro profile of FNZ controlled releases corresponded mainly to a kinetic Higuchi model. The in vitro/in vivo biological studies revealed non-toxicity and relevant tumor-weight diminution (up to 61%).
Collapse
Affiliation(s)
- Nicole Lecot
- Laboratorio de Radiofarmacia, Centro de Investigaciones Nucleares, Facultad de Ciencias, Universidad de la República, Mataojo 2055, Montevideo 11400, Uruguay; (P.C.); (H.C.)
- Grupo de Química Orgánica Medicinal, Instituto de Química Biológica, Facultad de Ciencias, Universidad de la República, Mataojo 2055, Montevideo 11400, Uruguay; (B.D.); (C.S.); (M.G.)
| | - Belén Dávila
- Grupo de Química Orgánica Medicinal, Instituto de Química Biológica, Facultad de Ciencias, Universidad de la República, Mataojo 2055, Montevideo 11400, Uruguay; (B.D.); (C.S.); (M.G.)
| | - Carina Sánchez
- Grupo de Química Orgánica Medicinal, Instituto de Química Biológica, Facultad de Ciencias, Universidad de la República, Mataojo 2055, Montevideo 11400, Uruguay; (B.D.); (C.S.); (M.G.)
| | - Marcelo Fernández
- Laboratorio de Experimentación Animal, Centro de Investigaciones Nucleares, Facultad de Ciencias, Universidad de la República, Mataojo 2055, Montevideo 11400, Uruguay;
| | - Mercedes González
- Grupo de Química Orgánica Medicinal, Instituto de Química Biológica, Facultad de Ciencias, Universidad de la República, Mataojo 2055, Montevideo 11400, Uruguay; (B.D.); (C.S.); (M.G.)
| | - Pablo Cabral
- Laboratorio de Radiofarmacia, Centro de Investigaciones Nucleares, Facultad de Ciencias, Universidad de la República, Mataojo 2055, Montevideo 11400, Uruguay; (P.C.); (H.C.)
| | - Hugo Cerecetto
- Laboratorio de Radiofarmacia, Centro de Investigaciones Nucleares, Facultad de Ciencias, Universidad de la República, Mataojo 2055, Montevideo 11400, Uruguay; (P.C.); (H.C.)
- Grupo de Química Orgánica Medicinal, Instituto de Química Biológica, Facultad de Ciencias, Universidad de la República, Mataojo 2055, Montevideo 11400, Uruguay; (B.D.); (C.S.); (M.G.)
| | - Romina Glisoni
- Departamento de Tecnología Farmacéutica, Facultad de Farmacia y Bioquímica, Universidad de Buenos Aires, Junín 956, Buenos Aires C1113AAD, Argentina
- Instituto de Nanobiotecnología (NANOBIOTEC), CONICET-Universidad de Buenos Aires, Junín 956, Buenos Aires C1113AAD, Argentina
| |
Collapse
|
4
|
Jeevarathinam AS, Lemaster JE, Chen F, Zhao E, Jokerst JV. Photoacoustic Imaging Quantifies Drug Release from Nanocarriers via Redox Chemistry of Dye-Labeled Cargo. Angew Chem Int Ed Engl 2020; 59:4678-4683. [PMID: 31840357 PMCID: PMC7101078 DOI: 10.1002/anie.201914120] [Citation(s) in RCA: 54] [Impact Index Per Article: 13.5] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/05/2019] [Indexed: 12/12/2022]
Abstract
We report a new approach to monitor drug release from nanocarriers via a paclitaxel-methylene blue conjugate (PTX-MB) with redox activity. This construct is in a photoacoustically silent reduced state inside poly(lactic-co-glycolic acid) (PLGA) nanoparticles (PTX-MB@PLGA NPs). During release, PTX-MB is spontaneously oxidized to produce a concentration-dependent photoacoustic signal. An in vitro drug-release study showed an initial burst release (25 %) between 0-24 h and a sustained release between 24-120 h with a cumulative release of 40.6 % and a 670-fold increase in photoacoustic signal. An in vivo murine drug release showed a photoacoustic signal enhancement of up to 649 % after 10 hours. PTX-MB@PLGA NPs showed an IC50 of 78 μg mL-1 and 44.7±4.8 % decrease of tumor burden in an orthotopic model of colon cancer via luciferase-positive CT26 cells.
Collapse
Affiliation(s)
| | - Jeanne E. Lemaster
- Department of NanoEngineering, University of California San Diego, 9500 Gilman Drive, La Jolla, CA, 92093, USA
| | - Fang Chen
- Department of NanoEngineering, University of California San Diego, 9500 Gilman Drive, La Jolla, CA, 92093, USA
- Department of Radiology, University of California, San Diego, 9500 Gilman Dr., La Jolla, CA 92093, USA
| | - Eric Zhao
- Department of NanoEngineering, University of California San Diego, 9500 Gilman Drive, La Jolla, CA, 92093, USA
| | - Jesse V. Jokerst
- Department of NanoEngineering, University of California San Diego, 9500 Gilman Drive, La Jolla, CA, 92093, USA
- Materials Science and Engineering Program, University of California, San Diego, 9500 Gilman Dr., La Jolla, CA 92093, USA
- Department of Radiology, University of California, San Diego, 9500 Gilman Dr., La Jolla, CA 92093, USA
| |
Collapse
|
5
|
Jeevarathinam AS, Lemaster JE, Chen F, Zhao E, Jokerst JV. Photoacoustic Imaging Quantifies Drug Release from Nanocarriers via Redox Chemistry of Dye‐Labeled Cargo. Angew Chem Int Ed Engl 2020. [DOI: 10.1002/ange.201914120] [Citation(s) in RCA: 12] [Impact Index Per Article: 3.0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/06/2022]
Affiliation(s)
| | - Jeanne E. Lemaster
- Department of NanoEngineering University of California San Diego 9500 Gilman Drive La Jolla CA 92093 USA
| | - Fang Chen
- Department of NanoEngineering University of California San Diego 9500 Gilman Drive La Jolla CA 92093 USA
- Department of Radiology University of California San Diego 9500 Gilman Dr. La Jolla CA 92093 USA
- Current address: Stanford University USA
| | - Eric Zhao
- Department of NanoEngineering University of California San Diego 9500 Gilman Drive La Jolla CA 92093 USA
| | - Jesse V. Jokerst
- Department of NanoEngineering University of California San Diego 9500 Gilman Drive La Jolla CA 92093 USA
- Materials Science and Engineering Program University of California San Diego 9500 Gilman Dr. La Jolla CA 92093 USA
- Department of Radiology University of California San Diego 9500 Gilman Dr. La Jolla CA 92093 USA
| |
Collapse
|
6
|
Yuan Q, Wang Y, Song R, Hou X, Yu K, Zheng J, Zhang J, Pu X, Han J, Zong L. Study on Formulation, in vivo Exposure, and Passive Targeting of Intravenous Itraconazole Nanosuspensions. Front Pharmacol 2019; 10:225. [PMID: 30983994 PMCID: PMC6447661 DOI: 10.3389/fphar.2019.00225] [Citation(s) in RCA: 9] [Impact Index Per Article: 1.8] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/10/2019] [Accepted: 02/22/2019] [Indexed: 12/28/2022] Open
Abstract
The pharmacokinetic profile of a drug can be different when delivered as a nanosuspension compared with a true solution, which may in turn affect the therapeutic effect of the drug. The goal of this study was to prepare itraconazole nanosuspensions (ITZ-Nanos) stabilized by an amphipathic polymer, polyethylene glycol-poly (benzyl aspartic acid ester) (PEG-PBLA), by the precipitation-homogenization, and study the pharmacokinetic profile of the ITZ-Nanos. The particle size and morphology of nanosuspensions were determined by Zetasizer and field emission scanning electron microscope (SEM), respectively. The dissolution profile was evaluated using a paddle method according to Chinese Pharmacopoeia 2015. The level of ITZ in plasma and tissues was measured by a HPLC method. The optimized ITZ-Nanos had an average particle size of 268.1 ± 6.5 nm and the particles were in a rectangular form. The dissolution profile of ITZ-Nanos was similar to that of commercial ITZ injections, with nearly 90% ITZ released in the first 5 min. The ITZ-Nanos displayed different pharmacokinetic properties compared with the commercial ITZ injections, including a decreased initial drug concentration, increased plasma half-life and mean residence time (MRT), and increased concentration in the liver, lung, and spleen. The ITZ-Nanos can change the in vivo distribution of ITZ and result in passive targeting to the organs with mononuclear phagocyte systems (MPS).
Collapse
Affiliation(s)
- Qi Yuan
- School of Pharmacy, Institute of Materia Medica, Henan University, Kaifeng, China
| | - Yanling Wang
- School of Pharmacy, Institute of Materia Medica, Henan University, Kaifeng, China
| | - Rufeng Song
- School of Pharmacy, Institute of Materia Medica, Henan University, Kaifeng, China
| | - Xianqiao Hou
- School of Pharmacy, Institute of Materia Medica, Henan University, Kaifeng, China
| | - Keke Yu
- School of Pharmacy, Institute of Materia Medica, Henan University, Kaifeng, China
| | - Jiaojiao Zheng
- School of Pharmacy, Institute of Materia Medica, Henan University, Kaifeng, China
| | - Juanmei Zhang
- School of Pharmacy, Institute of Materia Medica, Henan University, Kaifeng, China
| | - Xiaohui Pu
- School of Pharmacy, Institute of Materia Medica, Henan University, Kaifeng, China
| | - Jihong Han
- School of Pharmacy, The Institute for Science and Technology in Medicine, Keele University, Staffordshire, United Kingdom
| | - Lanlan Zong
- School of Pharmacy, The Institute for Science and Technology in Medicine, Keele University, Staffordshire, United Kingdom
| |
Collapse
|
7
|
Zhang Y, Mao Z, Wang B, Zhang J, Lu N, Hong R, Dong S, Yao C, Liu QH. Enhanced Antitumor Efficacy Achieved Through Combination of nsPEFs and Low-Dosage Paclitaxel. IEEE Trans Biomed Eng 2019; 66:3129-3135. [PMID: 30794505 DOI: 10.1109/tbme.2019.2900720] [Citation(s) in RCA: 8] [Impact Index Per Article: 1.6] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/10/2022]
Abstract
Looking for a safe and effective cancer therapy for patients is becoming an important and promising research direction. Nanosecond pulsed electric field (nsPEF) has been found to be a potential non-thermal therapeutic technique with few side effects in pre-clinical studies. On the other hand, paclitaxel (PTX), as a common chemotherapeutic agent, shows full anti-tumor activities and is used to treat a wide variety of cancers. However, the delivery of PTX is challenging due to its poor aqueous solubility. Hence, high dosages of PTX have been used to achieve effective treatment, which creates some side effects. In this study, nsPEF was combined with low-level PTX, in order to validate if this combined treatment could bring about enhanced efficacy and allow reduced doses of PTX in clinical application. Cell proliferation, apoptosis, and cell cycle distribution were examined using MTT and flow cytometry assay, respectively. Results showed that combination treatments of nsPEF and PTX exhibited significant synergistic effects in vitro. The underlying mechanism might be that these two agents acted at different targets and coordinately enhanced MDA-MB-231 cell death.
Collapse
|
8
|
Ahire E, Thakkar S, Darshanwad M, Misra M. Parenteral nanosuspensions: a brief review from solubility enhancement to more novel and specific applications. Acta Pharm Sin B 2018; 8:733-755. [PMID: 30245962 PMCID: PMC6146387 DOI: 10.1016/j.apsb.2018.07.011] [Citation(s) in RCA: 54] [Impact Index Per Article: 9.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/16/2018] [Revised: 04/20/2018] [Accepted: 06/26/2018] [Indexed: 02/01/2023] Open
Abstract
Advancements in in silico techniques of lead molecule selection have resulted in the failure of around 70% of new chemical entities (NCEs). Some of these molecules are getting rejected at final developmental stage resulting in wastage of money and resources. Unfavourable physicochemical properties affect ADME profile of any efficacious and potent molecule, which may ultimately lead to killing of NCE at final stage. Numerous techniques are being explored including nanocrystals for solubility enhancement purposes. Nanocrystals are the most successful and the ones which had a shorter gap between invention and subsequent commercialization of the first marketed product. Several nanocrystal-based products are commercially available and there is a paradigm shift in using approach from simply being solubility enhancement technique to more novel and specific applications. Some other aspects in relation to parenteral nanosuspensions are concentrations of surfactant to be used, scalability and in vivo fate. At present, there exists a wide gap due to poor understanding of these critical factors, which we have tried to address in this review. This review will focus on parenteral nanosuspensions, covering varied aspects especially stabilizers used, GRAS (Generally Recognized as Safe) status of stabilizers, scalability challenges, issues of physical and chemical stability, solidification techniques to combat stability problems and in vivo fate.
Collapse
Key Words
- ADME, absorption distribution metabolism elimination
- ASEs, aerosols solvent extractions
- AUC, area under curve
- BBB, blood–brain barrier
- BCS, Biopharmaceutical Classification System
- BDP, beclomethasone dipropionate
- CFC, critical flocculation concentration
- CLSM, confocal laser scanning microscopy
- CMC, critical micelle concentration
- DMSO, dimethyl sulfoxide
- EDI, estimated daily intake
- EHDA, electrohydrodynamic atomization
- EPAS, evaporative precipitation in aqueous solution
- EPR, enhanced permeability and retention
- FITC, fluorescein isothiocyanate
- GRAS, Generally Recognized as Safe
- HEC, hydroxyethylcellulose
- HFBII, class II hydrophobin
- HP-PTX/NC, hyaluronic acid-paclitaxel/nanocrystal
- HPC, hydroxypropyl cellulose
- HPH, high-pressure homogenization
- HPMC, hydroxypropyl methylcellulose
- IM, intramuscular
- IP, intraperitoneal
- IV, intravenous
- IVIVC, in vivo–in vitro correlation
- In vivo fate
- LD50, median lethal dose (50%)
- MDR, multidrug resistance effect
- NCE, new chemical entities
- Nanosuspension
- P-gp, permeation glycoprotein
- PEG, polyethylene glycol
- PTX, paclitaxel
- PVA, polyvinyl alcohol
- Parenteral
- QbD, quality by design
- SC, subcutaneous
- SEDS, solution enhanced dispersion by supercritical fluids
- SEM, scanning electron microscopy
- SFL, spray freezing into liquids
- Scalability
- Solidification
- Stabilizer
- TBA, tert-butanol
- TEM, transmission electron microscopy
- US FDA, United States Food and Drug Administration
- Vitamin E TPGS, d-α-tocopheryl polyethylene glycol 1000 succinate
Collapse
Affiliation(s)
| | | | | | - Manju Misra
- Department of Pharmaceutics, National Institute of Pharmaceutical Education and Research (NIPER), Ahmedabad, Gujarat 380054, India
| |
Collapse
|
9
|
Tran BN, Nguyen HT, Kim JO, Yong CS, Nguyen CN. Developing combination of artesunate with paclitaxel loaded into poly-d,l-lactic-co-glycolic acid nanoparticle for systemic delivery to exhibit synergic chemotherapeutic response. Drug Dev Ind Pharm 2017; 43:1952-1962. [DOI: 10.1080/03639045.2017.1357729] [Citation(s) in RCA: 12] [Impact Index Per Article: 1.7] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/28/2022]
Affiliation(s)
- Bao Ngoc Tran
- Department of Pharmaceutical Industry, Hanoi University of Pharmacy, Hanoi, Vietnam
| | - Hanh Thuy Nguyen
- College of Pharmacy, Yeungnam University, Gyeongsan, South Korea
| | - Jong Oh Kim
- College of Pharmacy, Yeungnam University, Gyeongsan, South Korea
| | - Chul Soon Yong
- College of Pharmacy, Yeungnam University, Gyeongsan, South Korea
| | - Chien Ngoc Nguyen
- Department of Pharmaceutical Industry, Hanoi University of Pharmacy, Hanoi, Vietnam
- National Institute of Pharmaceutical Technology, Hanoi University of Pharmacy, Hanoi, Vietnam
| |
Collapse
|
10
|
Jaksch S, Schulz A, Di Z, Luxenhofer R, Jordan R, Papadakis CM. Amphiphilic Triblock Copolymers from Poly(2-oxazoline) with Different Hydrophobic Blocks: Changes of the Micellar Structures upon Addition of a Strongly Hydrophobic Cancer Drug. MACROMOL CHEM PHYS 2016. [DOI: 10.1002/macp.201500465] [Citation(s) in RCA: 26] [Impact Index Per Article: 3.3] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/02/2023]
Affiliation(s)
- Sebastian Jaksch
- Physik-Department; Physik weicher Materie; Technische Universität München; James-Franck-Str. 1 85748 Garching Germany
| | - Anita Schulz
- Department Chemie; Professur für Makromolekulare Chemie; Technische Universität Dresden; Mommsenstr. 4 01069 Dresden Germany
| | - Zhenyu Di
- Jülich Centre for Neutron Science JCNS; Forschungszentrum Jülich GmbH; Outstation at MLZ; Lichtenbergstr. 1 85748 Garching Germany
| | - Robert Luxenhofer
- Functional Polymer Materials; Chair of Chemical Technology of Materials Synthesis; University Würzburg; Röntgenring 11 97070 Würzburg Germany
| | - Rainer Jordan
- Department Chemie; Professur für Makromolekulare Chemie; Technische Universität Dresden; Mommsenstr. 4 01069 Dresden Germany
| | - Christine M. Papadakis
- Physik-Department; Physik weicher Materie; Technische Universität München; James-Franck-Str. 1 85748 Garching Germany
| |
Collapse
|